High-quality medicines for changing patient needs
We supply a broad range of injectable medicines to treat diseases across therapeutic categories that include anti-infectives, pain management, central nervous system and oncology. Globally, including Europe, we supply over 200 generic injectable medicines. We are also developing a growing pipeline of new products.
Related news
Hikma launches Imatinib Mesylate Tablets
29 October 2018
Hikma launches AdriamycinTM (DOXOrubicin HCl) for Injection, USP
17 September 2018
Hikma launches Sterile Water for Injection, USP
13 August 2018